Based on the available research, it appears that any side effects experienced by test subjects as a result of ipamorelin administration are minor and dose-dependent
At Onyx Biolabs, every batch of our Ipamorelin undergoes rigorous, independent third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing within the USA
IGF-1 is the main anabolic mediator of hGHs actions and its levels are beleived to correlate to mean growth hormone levels
The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
Typically, the treatment involves administering small injections just under the skin, often on a cycle like five days a week
No clinical trial has tested ipamorelin for the GH-optimization, body-composition, or anti-aging uses people care about today